In December, President Obama signed into law the 21st Century Cures Act, which further directs the F. D. A. to remove barriers to approval, requiring that the agency consider the "least burdensome" means of showing the safety of medical devices, and consider feedback from patients. One of the biggest jobs of the F. D. A. â€™s next leader, said Dr. Jerry Avorn, a professor at Harvard Medical School who studies the drug industry, will be translating that law into reality. " Whoever is the new commissioner," he said, "is going is have both marching orders, and a blank slate. 